Does OSIMERTINIB Cause Thrombocytopenia? 220 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 220 reports of Thrombocytopenia have been filed in association with OSIMERTINIB (TAGRISSO). This represents 0.8% of all adverse event reports for OSIMERTINIB.
220
Reports of Thrombocytopenia with OSIMERTINIB
0.8%
of all OSIMERTINIB reports
34
Deaths
64
Hospitalizations
How Dangerous Is Thrombocytopenia From OSIMERTINIB?
Of the 220 reports, 34 (15.5%) resulted in death, 64 (29.1%) required hospitalization, and 23 (10.5%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for OSIMERTINIB.
What Other Side Effects Does OSIMERTINIB Cause?
Death (10,423)
Malignant neoplasm progression (2,920)
Diarrhoea (1,408)
Drug resistance (1,026)
Fatigue (819)
Rash (772)
Decreased appetite (706)
Drug ineffective (627)
Dyspnoea (621)
Nausea (610)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which OSIMERTINIB Alternatives Have Lower Thrombocytopenia Risk?
OSIMERTINIB vs OSPEMIFENE
OSIMERTINIB vs OSPHENA
OSIMERTINIB vs OVINE DIGOXIN IMMUNE FAB
OSIMERTINIB vs OXACILLIN
OSIMERTINIB vs OXALIPLATIN